Pegihep 50 MCG Injection 1 is used to manage chronic hepatitis C virus infections in patients with compensated liver disease. It belongs to a class of medicines known as biological response modifiers, specifically pegylated interferons.
In addition to treating chronic hepatitis C, this medicine can also be used as an adjuvant treatment for melanoma after surgical removal. When used for hepatitis C, it may be administered alone or combined with other antiviral medicines, depending on your specific virus genotype and individual health factors.
This medicine should be administered only under the supervision of a qualified doctor who will determine the appropriate dosage and frequency based on your body weight, virus type, and response to therapy. Before beginning treatment, inform your doctor about any pre-existing conditions and any medicines you are currently taking. Report any side effects you experience to your doctor promptly. Continue the treatment for the full duration prescribed by your doctor to achieve optimal results.